These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9569908)

  • 21. Rhabdomyolysis associated with gemfibrozil-colchicine therapy.
    Atmaca H; Sayarlioglu H; Külah E; Demircan N; Akpolat T
    Ann Pharmacother; 2002 Nov; 36(11):1719-21. PubMed ID: 12398566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypothyroidism, hypocholesteremic agents and rhabdomyolysis].
    Gouton M
    Arch Mal Coeur Vaiss; 1993 Dec; 86(12):1761-4. PubMed ID: 8024378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination drug therapy for combined hyperlipidemia.
    Guyton JR
    Curr Cardiol Rep; 1999 Sep; 1(3):244-50. PubMed ID: 10980849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Jamal SM; Eisenberg MJ; Christopoulos S
    Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-lowering agents and myopathy.
    Wortmann RL
    Curr Opin Rheumatol; 2002 Nov; 14(6):643-7. PubMed ID: 12410084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-lowering drugs: are adverse effects predictable and reversible?
    Muscari A; Puddu GM; Puddu P
    Cardiology; 2002; 97(3):115-21. PubMed ID: 12077562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
    Dopazo C; Bilbao I; Lázaro JL; Sapisochin G; Caralt M; Blanco L; Castells L; Charco R
    Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
    Lasocki A; Vote B; Fassett R; Zamir E
    Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined organ failure with combination antihyperlipidemic treatment: a case of hepatic injury and acute renal failure.
    Akoglu H; Yilmaz R; Kirkpantur A; Arici M; Altun B; Turgan C
    Ann Pharmacother; 2007 Jan; 41(1):143-7. PubMed ID: 17148651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of statins in clinical practice.
    Armitage J
    Lancet; 2007 Nov; 370(9601):1781-90. PubMed ID: 17559928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal rhabdomyolysis caused by lipid-lowering therapy.
    Federman DG; Hussain F; Walters AB
    South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gabapentin-induced severe myopathy.
    Tuccori M; Lombardo G; Lapi F; Vannacci A; Blandizzi C; Del Tacca M
    Ann Pharmacother; 2007 Jul; 41(7):1301-5. PubMed ID: 17565043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is every case of muscle damage during hypolipemic therapy the side effect of this therapy? A case report].
    Kedzia A; Krysiak R; Madej A; Okopień B
    Pol Arch Med Wewn; 2007 Oct; 117(10):473-6. PubMed ID: 18320790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute alcoholic myopathy, rhabdomyolysis and acute renal failure: a case report.
    Singh S; Sharma A; Sharma S; Sud A; Wanchu A; Bambery P
    Neurol India; 2000 Mar; 48(1):84-5. PubMed ID: 10751822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: a case report and review of the literature.
    Marot A; Morelle J; Chouinard VA; Jadoul M; Lambert M; Demoulin N
    Acta Clin Belg; 2011; 66(2):134-6. PubMed ID: 21630612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.
    Corpier CL; Jones PH; Suki WN; Lederer ED; Quinones MA; Schmidt SW; Young JB
    JAMA; 1988 Jul; 260(2):239-41. PubMed ID: 3290520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myotoxicity associated with lipid-lowering drugs.
    Baer AN; Wortmann RL
    Curr Opin Rheumatol; 2007 Jan; 19(1):67-73. PubMed ID: 17143099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis.
    Andrade SE; Graham DJ; Staffa JA; Schech SD; Shatin D; La Grenade L; Goodman MJ; Platt R; Gurwitz JH; Chan KA
    J Clin Epidemiol; 2005 Feb; 58(2):171-4. PubMed ID: 15680751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin myopathy as a metabolic muscle disease.
    Phillips PS; Haas RH
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.